SLFN11 and neoplasm: By implementing analytic pipelines in clinical material, we demonstrate, for the first time to our knowledge, that SLFN11 in both the neoplastic and microenvironmental compartments of tumor specimens modulates the response to platinum-containing regimens in patients with HGSOC.